Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
309 studies found for:    Open Studies | "Embolism and Thrombosis"
Show Display Options
Rank Status Study
1 Unknown  TCD Detection of Gas and Solid Micro-Emboli in Patients Undergoing Coronary Artery Bypass Grafting (CABG): The Influence of Proximal Anastomosis Technique
Conditions: Intracranial Embolism and Thrombosis;   Postoperative Complications
Intervention: Device: Proximal anastomosis using Heartstring anastomotic device
2 Not yet recruiting Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography
Conditions: Embolism and Thrombosis of the Radial Artery;   Coronary Heart Disease
Interventions: Device: Glidesheath Slender;   Device: standard 6- French radial sheath
3 Recruiting A Complex Contraception Registry
Conditions: Diabetes;   Cardiovascular Disease;   Epilepsy;   Migraine;   Neurological Disorders;   Cancer;   Bariatric Surgery Candidate;   Organ or Tissue Transplant; Complications;   Lupus Erythematosus, Systemic;   Other Hematologic Conditions;   Other Venous Embolism and Thrombosis
Intervention:
4 Unknown  Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion
Conditions: Intracranial Embolism;   Thrombosis
Intervention: Procedure: transcranial ultrasound in patients treated with iv t-PA
5 Unknown  Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:
6 Recruiting Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Recommended VTE pharmacological treatments according to international guidelines
7 Recruiting Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis
Condition: Sinus Thrombosis, Intracranial
Interventions: Drug: Endovascular thrombolysis;   Drug: Heparin
8 Recruiting Rheoparin-coated Tubing System for Minimized Extracorporeal Circulation (MECC)
Conditions: Extracorporeal Circulation;   Inflammation;   Blood Coagulation;   Intracranial Embolism
Intervention: Device: MECC system with rheoparin coating
9 Unknown  Incidence of Acute Cerebrovascular Events Using Either Minimized or Standard Cardiopulmonary Bypass Circuit
Conditions: Coronary Artery Disease;   Acute Cerebrovascular Accident;   Intracranial Embolism;   Embolism, Air
Intervention: Device: ROCsafeTM
10 Recruiting Rivaroxaban Anticoagulation for Superficial Vein Thrombosis
Condition: Symptomatic Superficial Vein Thrombosis
Interventions: Drug: Rivaroxaban;   Drug: Placebo
11 Not yet recruiting Cancer Venous Thromboembolism (VTE)
Conditions: Venous Thromboembolism (VTE);   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Cancer
Interventions: Drug: edoxaban;   Drug: Dalteparin
12 Recruiting Registry on WATCHMAN Outcomes in Real-Life Utilization
Condition: Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke
Intervention:
13 Recruiting Evaluation of the Duration of Therapy for Thrombosis in Children
Condition: Venous Thrombosis
Interventions: Other: Shortened duration (6 weeks) of anticoagulant therapy;   Other: Conventional duration (3 months) of anticoagulant therapy;   Other: No Intervention
14 Not yet recruiting Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation
Conditions: Atrial Fibrillation;   Cardioembolic Events;   Oral Anticoagulation
Intervention: Drug: Dabigatran
15 Unknown  Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence
Conditions: Pulmonary Disease, Chronic Obstructive;   Disease Exacerbation;   Pulmonary Embolism;   Prothrombin Fragments
Intervention: Other: CT pulmonary angio, blood tests
16 Unknown  VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
Conditions: Atrial Fibrillation;   Cardiac Thrombus;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Replacement (Mechanical or Biological With AF);   Cardiomyopathy (Ischemic or Dilated);   Peripheral Vascular Disease
Intervention: Drug: Warfarin dose titration
17 Recruiting Prevention of Recurrence After Thrombolysis in Acute Iliofemoral Venous Thrombosis (PRAIS) Study
Condition: Ileofemoral Deep Vein Thrombosis
Interventions: Drug: rivaroxaban;   Drug: Warfarin
18 Recruiting Nitric Oxide to Treat Pulmonary Embolism
Condition: Pulmonary Embolism
Interventions: Drug: Nitric Oxide;   Drug: Oxygen
19 Recruiting VTEval Project - A Prospective Cohort Study to Evaluate Diagnosis, Management and Outcome in Individuals With Venous Thromboembolism
Conditions: Venous Thromboembolism (VTE);   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE)
Intervention:
20 Recruiting Lung Ultrasound in Pleuritic Chest Pain
Conditions: Community Acquired Pneumonia;   Pleuritis;   Pulmonary Embolism;   Lung Cancer
Intervention: Procedure: Lung ultrasound

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years